MIR6083

Across TCGA pan-cancer cohorts, MIR6083 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR6083 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR6083 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6083 expression acts as an unfavorable survival marker.

ACC and STAD are the cancer types where MIR6083 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.155	0.672	.007	54	view →
STAD	OS	Tertile	All	0.134	0.550	.022	18	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR6083–ACC (DFS)

Open the ACC breakdown →